Search Results 651-660 of 19289 for autoimmune hepatitis
The purpose of this study is to perform retrospective data collection for a natural history study of LGI1 IgG seropositive patients seen at Mayo Clinic sites or ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...
Digestive and Liver Disease. 2022; doi:10.1016/j.dld.2022.01.123. Xeljanz, Xeljanz XR (tofacitinib): Drug safety communication — Initial safety trial ...
This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.
We'll also discuss a fairly novel approach to patients with obesity-related liver disease, which is to combine liver transplant with bariatric surgery. Obesity ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
Liver disease is one of the leading causes of death in the U.S. and the world, especially liver disease relating to excess alcohol consumption. While many ...
... hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received ...
Liver disease, advanced—May increase risk for bradycardia (slow heartbeat) and more serious side effects. Hepatitis B infection, history of—Use with caution.
Biliary fibrosis is the process of periportal scarring within the liver that is caused by diseased bile ducts. It often progresses to end-stage liver disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.